Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection | Zendy

Sophie Novelli | Zendy; Camille Lécuroux | Zendy; Véronique Avettand-Fènoël | Zendy; Rémonie Seng | Zendy; Asma Essat | Zendy; Philippe Morlat | Zendy; JeanPaul Viard | Zendy; Christine Rouzioux | Zendy; Laurence Meyer | Zendy; Cécile Goujard | Zendy

Open Access

Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection

Author(s) -

Sophie Novelli,

Camille Lécuroux,

Véronique Avettand-Fènoël,

Rémonie Seng,

Asma Essat,

Philippe Morlat,

JeanPaul Viard,

Christine Rouzioux,

Laurence Meyer,

Cécile Goujard

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix1068

Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , sida , term (time) , intensive care medicine , immunopathology , immunology , virology , viral disease , pediatrics , viral load , physics , quantum mechanics

We aimed to determine the consequences of delayed human immunodeficiency virus type 1 (HIV-1) infection diagnosis by comparing long-term outcomes depending on the time of combination antiretroviral therapy (cART) initiation in patients diagnosed during primary HIV infection (PHI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research